Clostridioides Difficile NAAT POCT Detection Kit

PCR-based nucleic acid test kit for rapid detection and identification of Clostridium difficile in clinical specimens. Employs fluorescence probe methodology for sensitive and specific diagnosis of C. difficile infection in gastrointestinal disease assessment. Suitable for use on standard PCR platforms in clinical microbiology laboratories.

Fluorescence PCR-based nucleic acid detection kit for rapid and accurate identification of Clostridium difficile Toxin B in clinical specimens. Enables differential diagnosis of C. difficile infection in patients presenting with nosocomial diarrhea and gastrointestinal symptoms. Delivers sensitive molecular detection with streamlined workflow for laboratory implementation.

Fecal specimen test for C. difficile detection with GDH sensitivity of 95.3%, Toxin A of 96.0%, and Toxin B of 94.7%. Contains 10 tests per kit with 10-minute turnaround and full regulatory certifications.

Molecular diagnostic test kit for detection of microbial pathogens using nucleic acid amplification techniques. Designed for clinical microbiology and infectious disease diagnostics.

Rapid diagnostic testing solution for point-of-care use in clinical settings. Enables quick identification of infections and diseases directly at the patient location.

A nucleic acid-based detection kit for identifying bacterial, viral, and parasitic pathogens causing diarrheal disease. Designed for rapid diagnosis in clinical and epidemiological settings.

Rapid diagnostic kit for detection of infectious diseases including COVID-19, providing point-of-care results within 10 minutes for serology testing and laboratory molecular results in 83 minutes or less. FDA EUA-cleared for determining past exposure and immune response.

Rapid test kit for detection of SARS-CoV-2 nucleic acid in respiratory samples. Provides quick results suitable for point-of-care and laboratory settings.

Rapid diagnostic test for qualitative detection of gastrointestinal pathogen markers. Point-of-care assay for screening gastrointestinal infections.

An in vitro diagnostic test kit for COVID-19 detection using direct PCR methodology. The kit provides rapid molecular detection capabilities for clinical laboratory environments.

Molecular detection kit for Candida auris fungal pathogen. Used for rapid identification of this multidrug-resistant fungal infection.

Point-of-care testing reagent for in vitro diagnostic applications enabling rapid clinical assessment. Designed for distributed laboratory and bedside diagnostic implementation.